Density and pharmacology of α5 subunit-containing GABA(A) receptors are preserved in hippocampus of Alzheimer's disease patients

Neuroscience

Volumn 98, Issue 4, 2000, Pages 669-675

  Howell, O ^a   Atack, J R ^a   Dewar, D ^b   McKernan, R M ^a   Sur, C ^a  

^a NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Autoradiography; Benzodiazepines; Cognition; Human; L 655,708

Indexed keywords

2 PHENYL 5H PYRAZOLO[4,3 C]QUINOLIN 3 ONE; 3 METHYL 6 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 TRIAZOLO[4,3 B]PYRIDAZINE; 4 AMINOBUTYRIC ACID A RECEPTOR; 8 AZIDO 5,6 DIHYDRO 5 METHYL 6 OXO 4H IMIDAZO[1,5 A][1,4]BENZODIAZEPINE 3 CARBOXYLIC ACID ETHYL ESTER; BENZODIAZEPINE; DIAZEPAM; FLUNITRAZEPAM; IMIDAZOLE DERIVATIVE; L 655,708; LIGAND;

ALZHEIMER DISEASE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; COGNITION; CONTROLLED STUDY; DENTATE GYRUS; DRUG RECEPTOR BINDING; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; AGED; CASE CONTROL STUDY; METABOLISM; PATHOLOGY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; HIPPOCAMPUS; HUMANS; IMIDAZOLES; LIGANDS; RECEPTORS, GABA-A;

EID: 0033623829     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00163-9     Document Type: Article

References (37)

1. Abe K., Takeyama C., Yoshimura K. Effects of S-8510, a novel benzodiazepine receptor partial inverse agonist, on basal forebrain lesioning-induced dysfunction in rats. Eur. J. Pharmacol. 347:1998;145-152.
2. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature, Lond. 363:1993;347-350.
3. Bonnert T., McKernan R., Farrar S., LeBourdelles B., Heavens R.P., Smith D.W., Hewson L., Rigby M.R., Sirinathsinghji D.J.S., Brown N., Wafford K.A., Whiting P.J. θ, a novel γ-aminobutyric acid type A receptor subunit. Proc. natn. Acad. Sci. U.S.A. 96:1999;9891-9896.
4. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta neuropath. 82:1991;239-259.
5. 50) of an enzymatic reaction. Biochem. Pharmac. 22:1973;3099-3108.
6. A receptor changes in Alzheimer's disease. Neurosci. Lett. 82:1987;246-252.
7. Costa E., Guidotti A. Benzodiazepines on trial: a research strategy for their rehabilitation. Trends pharmac. Sci. 17:1996;192-200.
8. Cross A.J., Crow T.J., Johnson J.A., Perry E.K., Perry R.H., Blessed G., Tomlinson B.E. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer type. J. neurol. Sci. 64:1984;109-117.
9. Dewar D., Chalmers D.T., Graham D.I., McCulloch J. Glutamate metabotropic and AMPA binding sites are reduced in Alzheimer's disease: an autoradiographic study of the hippocampus. Brain Res. 553:1991;58-64.
10. Duka T. and Dorrow R. (1995) Human experimental psycho-pharmacology of benzodiazepine receptor inverse agonists and antagonists. In Benzodiazepine receptor inverse agonists (eds Sarter M., Nutt D. J. and Lister R. G.), pp. 243-270. Wiley-Liss, New York.
11. A receptors. Neuropharmacology. 35:1996;347-357.
12. A receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits. J. comp. Neurol. 359:1995;154-194.
13. 3H]glutamate binding. J. Neurochem. 48:1987;543-551.
14. A receptors in the human hippocampal formation. J. Neurosci. 8:1988;1370-1383.
15. A receptor in the human hippocampus and its preservation in Alzheimer's disease. Br. J. Pharmac. 128:1999;292P.
16. Jansen K.L.R., Faull R.L.M., Dragunow M., Synek B.L. Alzheimer's disease: changes in hippocampal N-methyl-D-aspartate, quisqualate, neurotensin, adenosine, benzodiazepine, serotonin and opiod receptors - an autoradiographic study. Neuroscience. 39:1990;613-627.
17. Kawasaki K., Eigyo M., Ikeda M., Kihara T., Koike K., Matsushita A., Murata S., Shiomi T., Takada S., Yasui M. A novel benzodiazepine inverse agonist, S-8510, as a cognitive enhancer. Prog. Neuro-Psychopharmac. biol. Psychiat. 20:1996;1413-1425.
18. Khatchaturian Z.S. Diagnosis of Alzheimer's disease. Archs Neurol. 42:1985;1097-1105.
19. A receptor subunits in the human brain. J. Histochem. Cytochem. 46:1998;1129-1140.
20. A-receptor subtypes really occur in the brain? Trends Neurosci. 19:1996;139-143.
21. A receptor β2/3 subunits in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Exp. Neurol. 147:1997;333-345.
22. A receptor β2 and β3 subunits mRNA in the hippocampal formation of aged human brain with Alzheimer-related neuropathology. Mol. Brain Res. 56:1998a;268-272.
23. A receptor α1 subunit in the hippocampal formation of aged brains with Alzheimer-related neuropathologic changes. Brain Res. 799:1998b;148-155.
24. Paulsen O., Moser E.I. A model of hippocampal memory encoding and retrieval: gabaergic control of synaptic plasticity. Trends Neurosci. 21:1998;273-278.
25. Penny J.B., Maragos W.F., Greenamyre J.T., Debowey D.L., Hollingsworth Z., Young A.B. Excitatory amino acid binding sites in the hippocampal region of Alzheimer's disease and other dementias. J. Neurol. Neurosurg. Psychiatry. 53:1990;314-320.
26. A receptor α5-subunit creates novel type II benzodiazepine receptor pharmacology. J. Neurochem. 54:1990;1802-1804.
27. A receptors which contain the α5 subunit. Neuropharmacology. 35:1996;1331-1335.
28. A receptor benzodiazepine site ligands. Neuropharmacology. 36:1997;823-830.
29. A receptor subtypes. Pharmacol. Rev. 47:1995;181-234.
30. A receptor in post-mortem human brain. Soc. Neurosci. Abst. 21:1995;354.
31. Sirinathsinghji D.J.S. Transgenic models of Alzheimer's disease. Curr. Res. Alzheimer's Dis. 3:1998;47-56.
32. A receptors have α5β3γ2 pharmacological characteristics. Mol. Pharmac. 54:1998;928-933.
33. A receptors in rat brain. Brain Res. 822:1999;265-270.
34. Tsien J.Z., Huerta P.T., Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell. 87:1996;1327-1338.
35. A receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon and mesencephalon. J. Neurosci. 12:1992;1040-1062.
36. Yasui M., Kawasaki K., Matsushita A., Satoh M. Benzodiazepine inverse agonists augment long-term potentiation in CA1 and CA3 of guinea-pig hippocampal slices. Neuropharmacology. 32:1993;127-131.
37. Zilles K., Qu M., Schleicher A., Schroeter M., Kraemer M., Witte O.W. Plasticity and neurotransmitter receptor changes in Alzheimer's disease and experimental cortical infarcts. Drug Res. 45:1995;361-366.